Product NDC: | 0517-9120 |
Proprietary Name: | Aminocaproic Acid |
Non Proprietary Name: | Aminocaproic Acid |
Active Ingredient(s): | 250 mg/mL & nbsp; Aminocaproic Acid |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-9120 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071192 |
Marketing Category: | ANDA |
Start Marketing Date: | 19900930 |
Package NDC: | 0517-9120-25 |
Package Description: | 25 VIAL, MULTI-DOSE in 1 TRAY (0517-9120-25) > 20 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0517-9120-25 |
Proprietary Name | Aminocaproic Acid |
Package Description | 25 VIAL, MULTI-DOSE in 1 TRAY (0517-9120-25) > 20 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0517-9120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Aminocaproic Acid |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19900930 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | AMINOCAPROIC ACID |
Strength Number | 250 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |